3-Methylbenzylpiperazine
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Reba16 (talk | contribs) at 12:00, 26 May 2021. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.023.805 ![]() |
Chemical and physical data | |
Formula | C12H18N2 |
Molar mass | 190.290 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Methylbenzylpiperazine (3-Me-BZP) is a stimulant drug which is a derivative of benzylpiperazine. It has been sold as a designer drug, first being identified in Sweden in February 2012.[1]
See also
References
- ^ "EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)" (Document). Lisbon: EMCDDA. May 2013.
{{cite document}}
: Unknown parameter|url=
ignored (help)
Hidden categories:
- CS1 errors: unsupported parameter
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes